Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease.

Shili-Masmoudi S, Wong GL, Hiriart JB, Liu K, Chermak F, Shu SS, Foucher J, Tse YK, Bernard PH, Yip TC, Merrouche W, Chan HL, Wong VW, de Lédinghen V.

Liver Int. 2019 Nov 20. doi: 10.1111/liv.14301. [Epub ahead of print]

PMID:
31749300
2.

Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.

Petta S, Wai-Sun Wong V, Bugianesi E, Fracanzani AL, Cammà C, Hiriart JB, Lai-Hung Wong G, Vergniol J, Wing-Hung Chan A, Giannetti A, Merrouche W, Lik-Yuen Chan H, Le-Bail B, Lombardi R, Guastella S, Craxì A, de Ledinghen V.

Am J Gastroenterol. 2019 Jun;114(6):916-928. doi: 10.14309/ajg.0000000000000153.

PMID:
31169533
3.

New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.

Boursier J, Guillaume M, Leroy V, Irlès M, Roux M, Lannes A, Foucher J, Zuberbuhler F, Delabaudière C, Barthelon J, Michalak S, Hiriart JB, Peron JM, Gerster T, Le Bail B, Riou J, Hunault G, Merrouche W, Oberti F, Pelade L, Fouchard I, Bureau C, Calès P, de Ledinghen V.

J Hepatol. 2019 Aug;71(2):389-396. doi: 10.1016/j.jhep.2019.04.020. Epub 2019 May 16.

PMID:
31102719
4.

Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!

Berger A, Shili S, Zuberbuhler F, Hiriart JB, Lannes A, Chermak F, Hunault G, Foucher J, Oberti F, Fouchard-Hubert I, Cales P, de Ledinghen V, Boursier J.

Clin Transl Gastroenterol. 2019 Apr;10(4):e00023. doi: 10.14309/ctg.0000000000000023.

5.

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Zhu AX, Kang YK, Yen CJ, Finn RS, Galle PR, Llovet JM, Assenat E, Brandi G, Pracht M, Lim HY, Rau KM, Motomura K, Ohno I, Merle P, Daniele B, Shin DB, Gerken G, Borg C, Hiriart JB, Okusaka T, Morimoto M, Hsu Y, Abada PB, Kudo M; REACH-2 study investigators.

Lancet Oncol. 2019 Feb;20(2):282-296. doi: 10.1016/S1470-2045(18)30937-9. Epub 2019 Jan 18.

PMID:
30665869
6.

Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification.

Boursier J, Cassinotto C, Hunault G, Shili S, Lebigot J, Lapuyade B, Lannes A, Hiriart JB, Cartier V, Le Bail B, Michalak S, Mouries A, Oberti F, Chermak F, Fouchard-Hubert I, Cales P, Aube C, de Ledinghen V.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):164-171.e5. doi: 10.1016/j.cgh.2018.04.062. Epub 2018 May 9.

PMID:
29753082
7.

Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement.

Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Lédinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wong VW, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JB, Sarin SK, Badea R, Lee HW, Marcellin P, Filice C, Mahadeva S, Wong GL, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J.

Aliment Pharmacol Ther. 2018 Apr;47(7):989-1000. doi: 10.1111/apt.14529. Epub 2018 Feb 15.

8.

Assessment of Liver Disease Progression in Cystic Fibrosis Using Transient Elastography.

Gominon AL, Frison E, Hiriart JB, Vergniol J, Clouzeau H, Enaud R, Bui S, Fayon M, de Ledinghen V, Lamireau T.

J Pediatr Gastroenterol Nutr. 2018 Mar;66(3):455-460. doi: 10.1097/MPG.0000000000001822.

PMID:
29112089
9.

Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD.

Petta S, Wong VW, Cammà C, Hiriart JB, Wong GL, Vergniol J, Chan AW, Di Marco V, Merrouche W, Chan HL, Marra F, Le-Bail B, Arena U, Craxì A, de Ledinghen V.

Aliment Pharmacol Ther. 2017 Sep;46(6):617-627. doi: 10.1111/apt.14219. Epub 2017 Jul 27.

10.

Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy.

de Lédinghen V, Hiriart JB, Vergniol J, Merrouche W, Bedossa P, Paradis V.

Dig Dis Sci. 2017 Sep;62(9):2569-2577. doi: 10.1007/s10620-017-4638-3. Epub 2017 Jun 2.

PMID:
28577247
11.

Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter.

Wong VW, Petta S, Hiriart JB, Cammà C, Wong GL, Marra F, Vergniol J, Chan AW, Tuttolomondo A, Merrouche W, Chan HL, Le Bail B, Arena U, Craxì A, de Lédinghen V.

J Hepatol. 2017 Sep;67(3):577-584. doi: 10.1016/j.jhep.2017.05.005. Epub 2017 May 12.

PMID:
28506907
12.

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.

Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Lédinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wong VW, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JB, Sarin SK, Badea R, Jung KS, Marcellin P, Filice C, Mahadeva S, Wong GL, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J.

J Hepatol. 2017 May;66(5):1022-1030. doi: 10.1016/j.jhep.2016.12.022. Epub 2016 Dec 28.

PMID:
28039099
13.

Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.

Petta S, Wong VW, Cammà C, Hiriart JB, Wong GL, Marra F, Vergniol J, Chan AW, Di Marco V, Merrouche W, Chan HL, Barbara M, Le-Bail B, Arena U, Craxì A, de Ledinghen V.

Hepatology. 2017 Apr;65(4):1145-1155. doi: 10.1002/hep.28843. Epub 2016 Nov 5.

PMID:
27639088
14.

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

Boursier J, Vergniol J, Guillet A, Hiriart JB, Lannes A, Le Bail B, Michalak S, Chermak F, Bertrais S, Foucher J, Oberti F, Charbonnier M, Fouchard-Hubert I, Rousselet MC, Calès P, de Lédinghen V.

J Hepatol. 2016 Sep;65(3):570-8. doi: 10.1016/j.jhep.2016.04.023. Epub 2016 May 2.

PMID:
27151181
15.

Impact of Surgery and Valvuloplasty on Liver Stiffness in a Patient With Pericarditis and Pulmonary Valvulopathy.

Jalal Z, Iriart X, de Lédinghen V, Hiriart JB, Thambo JB.

World J Pediatr Congenit Heart Surg. 2017 Jan;8(1):103-105. doi: 10.1177/2150135115614575. Epub 2016 Jun 23.

PMID:
27009889
16.

Sexual quality of life is impaired in patients with chronic hepatitis C.

Vergniol J, Duc S, Hou G, Hiriart JB, Foucher J, Chenus F, Fabères C, Chermak F, Lafournière A, Souakri N, de Lédinghen V.

Int J Impot Res. 2016 Mar-Apr;28(2):68-73. doi: 10.1038/ijir.2016.5. Epub 2016 Feb 11.

PMID:
26865102
17.

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.

Cassinotto C, Boursier J, de Lédinghen V, Lebigot J, Lapuyade B, Cales P, Hiriart JB, Michalak S, Bail BL, Cartier V, Mouries A, Oberti F, Fouchard-Hubert I, Vergniol J, Aubé C.

Hepatology. 2016 Jun;63(6):1817-27. doi: 10.1002/hep.28394. Epub 2016 Jan 22.

PMID:
26659452
18.

Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.

de Lédinghen V, Wong GL, Vergniol J, Chan HL, Hiriart JB, Chan AW, Chermak F, Choi PC, Foucher J, Chan CK, Merrouche W, Chim AM, Le Bail B, Wong VW.

J Gastroenterol Hepatol. 2016 Apr;31(4):848-55. doi: 10.1111/jgh.13219.

PMID:
26514665
19.

Liver stiffness measurements for evaluation of central venous pressure in congenital heart diseases.

Jalal Z, Iriart X, De Lédinghen V, Barnetche T, Hiriart JB, Vergniol J, Foucher J, Thambo JB.

Heart. 2015 Sep;101(18):1499-504. doi: 10.1136/heartjnl-2014-307385. Epub 2015 Jun 17.

PMID:
26085526
20.

Liver and spleen elastography using supersonic shear imaging for the non-invasive diagnosis of cirrhosis severity and oesophageal varices.

Cassinotto C, Charrie A, Mouries A, Lapuyade B, Hiriart JB, Vergniol J, Gaye D, Hocquelet A, Charbonnier M, Foucher J, Laurent F, Chermak F, Montaudon M, de Ledinghen V.

Dig Liver Dis. 2015 Aug;47(8):695-701. doi: 10.1016/j.dld.2015.04.008. Epub 2015 Apr 20.

PMID:
25959234
21.

Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.

Cassinotto C, Lapuyade B, Mouries A, Hiriart JB, Vergniol J, Gaye D, Castain C, Le Bail B, Chermak F, Foucher J, Laurent F, Montaudon M, De Ledinghen V.

J Hepatol. 2014 Sep;61(3):550-7. doi: 10.1016/j.jhep.2014.04.044. Epub 2014 May 9.

PMID:
24815876
22.

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

de Lédinghen V, Vergniol J, Capdepont M, Chermak F, Hiriart JB, Cassinotto C, Merrouche W, Foucher J, Brigitte le B.

J Hepatol. 2014 May;60(5):1026-31. doi: 10.1016/j.jhep.2013.12.018. Epub 2013 Dec 28.

PMID:
24378529
23.

Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion.

Grise F, Sena S, Bidaud-Meynard A, Baud J, Hiriart JB, Makki K, Dugot-Senant N, Staedel C, Bioulac-Sage P, Zucman-Rossi J, Rosenbaum J, Moreau V.

Hepatology. 2012 Jun;55(6):1766-75. doi: 10.1002/hep.25568.

PMID:
22234932
24.

Perihilar cholangiocarcinoma, the need for a new staging system.

Hiriart JB, Laurent C, Blanc JF.

Clin Res Hepatol Gastroenterol. 2011 Nov;35(11):697-8. doi: 10.1016/j.clinre.2011.06.004. Epub 2011 Oct 5.

PMID:
21978440
25.

Cirrhosis and constitutional telomerase mutations.

Hiriart JB, Bioulac-Sage P, Balabaud C.

Clin Res Hepatol Gastroenterol. 2011 Oct;35(10):607-9. doi: 10.1016/j.clinre.2011.05.017. Epub 2011 Oct 5.

PMID:
21978439
26.

Depletion of the photosystem II core complex in mature tobacco leaves infected by the flavum strain of tobacco mosaic virus.

Lehto K, Tikkanen M, Hiriart JB, Paakkarinen V, Aro EM.

Mol Plant Microbe Interact. 2003 Dec;16(12):1135-44.

27.
28.

Suppression of a key gene involved in chlorophyll biosynthesis by means of virus-inducing gene silencing.

Hiriart JB, Lehto K, Tyystjärvi E, Junttila T, Aro EM.

Plant Mol Biol. 2002 Sep;50(2):213-24.

PMID:
12175014
29.

RNA-Mediated Virus Resistance: Role of Repeated Transgenes and Delineation of Targeted Regions.

Sijen T, Wellink J, Hiriart JB, Van Kammen A.

Plant Cell. 1996 Dec;8(12):2277-2294.

Supplemental Content

Loading ...
Support Center